Abstract
Men and women with suspected or proven genital infections caused by Chlamydia trachomatis were enrolled in a double-blind study to evaluate the efficacy and tolerability of fleroxacin. Patients received either 400, 600, or 800 mg once daily for 7 days and were monitored approximately 2, 4, and 7 weeks after initiation of therapy. In men monitored for at least 6 weeks or until failure of the therapy, fleroxacin failed to eradicate C. trachomatis in three of eight on the 400-mg regimen, in one of four on the 600-mg regimen, and in four of seven on the 800-mg regimen. All five women monitored for at least 6 weeks became culture negative. There was no association between in vitro susceptibility of C. trachomatis to fleroxacin and outcome, with MICs being 4 to 8 migrograms/ml for almost all isolates tested. Among those with positive cultures for Ureaplasma urealyticum initially, the first follow-up cultures remained positive in 8 (29%) of 28 men and 8 (50%) of 16 women. Independent of culture results, men with nongonococcal urethritis receiving 800 mg of fleroxacin were significantly more likely to show a clinical response than men receiving 400 or 600 mg (93 versus 54%). Adverse events were frequent, often severe, and dose related....Continue Reading
References
Nov 1, 1978·The Journal of Infectious Diseases·W R BowieE R Alexander
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·W R BowieP J Jewesson
Jul 1, 1988·Antimicrobial Agents and Chemotherapy·H MaedaS Kamidono
Mar 1, 1987·Antimicrobial Agents and Chemotherapy·W R BowieW A Black
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·J S Wolfson, D C Hooper
Feb 1, 1986·Annals of Internal Medicine·J N WasserheitD A Eschenbach
Oct 1, 1988·The Journal of Antimicrobial Chemotherapy·E WeidekammD Dell
Oct 1, 1988·The Journal of Antimicrobial Chemotherapy·R A PustH Meier-Ewert
Oct 1, 1988·The Journal of Antimicrobial Chemotherapy·O Steele-Mortimer, H Meier-Ewert
Jan 1, 1988·Reviews of Infectious Diseases·H Halkin
Apr 17, 1987·JAMA : the Journal of the American Medical Association·A E WashingtonL L Sanders
May 1, 1984·Drugs·W R Bowie
Oct 1, 1980·The British Journal of Venereal Diseases·W R BowieH D Jones
Citations
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A R Ronald, R W Peeling
Jan 1, 1993·International Journal of Antimicrobial Agents·W CullmannA Braunsteiner
Jul 1, 1994·International Journal of Antimicrobial Agents·R H RubinA J Fischman
Jun 9, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C Owens, Paul G Ambrose
Jul 25, 2000·Sexually Transmitted Diseases·M R GoldenM E St Louis
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·W R BowieP J Jewesson
Oct 1, 1993·Antimicrobial Agents and Chemotherapy·A J FischmanH W Strauss
Feb 7, 1991·The New England Journal of Medicine·D C Hooper, J S Wolfson
May 25, 2007·The Journal of Infection·Matthew E FalagasPetros I Rafailidis
Jan 27, 2019·The Cochrane Database of Systematic Reviews·Carol Páez-CanroHernando G Gaitán
Mar 1, 1996·Antimicrobial Agents and Chemotherapy·A J FischmanR H Rubin
Jan 13, 2001·The Medical Clinics of North America·R C Owens, P G Ambrose